Alpha lactalbumin is a whey protein, found among other places, in mothers milk. It has recently been in the news as the primary protein used in the search for a cure for breast cancer.

For the last eight years, Dr. Vincent Tuohy, at the Cleveland Clinic, has been searching for a vacine for breast cancer. Dr. Tuohy discovered that mice injected with the vaccine, based on Alpha lactalbumin, did not develop breast tumors, while 100 percent of the mice that were not vacinated, had breast tumors.

The vacine also seems to inhibit the growth of pre-existing tumors.

In an interview he also states that "There's nothing fancy about it. We're vaccinating against something that isn't there unless you have tumors, so it shouldn't harm you. And it should kill the tumors,".

The main part of the vaccine, a protein called Alpha lactalbumin found in lactating breasts, is also found in breast tumors, but not in healthy breasts. It is suggested that women who are finished breast feeding, would recieve the vaccine thus boosting their own immune systems and supplying the means to kill off cancerous cells while not damaging healthy ones.

"We think that breast cancer is a completely preventable disease in the same way that polio is completely preventable," Dr. Tuohy says.

This sort of research gives hope to anyone who has, or knows of anyone with breast cancer. To say nothing of outright prevention. In 2009, The American cancer society estimates that there was 192,370 new cases of invasive breast cancer and 40,170 deaths from breast cancer.

(c) 2010 Alphalactalbumin.com

Use of this article is forbidden without express permission from the author.

Research and Markets: Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation
Research and Markets has announced the addition of the "Frontier Pharma: Breast Cancer - Identifying and CommercRead More...

Breast Cancer Patients Seek More Control Over Research Agenda
Tired of waiting for a cure for breast cancer, a coalition of activists now leans hard on Congress to steer money to particular research projects. Critics say that approach may miss promising leads.Read More...

Agendia Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment
In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared to the use of conventional IHC-FISH pathology tests.Read More...

'Breast cancer gene' lawyers launch appeal to High court
Cancer advocates are taking "the breast cancer gene" case to the High Court in a last-ditch effort to overturn a controversial decision by the Federal Court.Read More...

ClearID Breast Cancer Genomic Test is Now Reimbursable under Most Health Insurance Plans
Cynvenio Biosystems, Inc. announced today that it will be accepting payment for its ClearID Breast Cancer test under most health insurance plans including Aetna, UnitedHealth GroupRead More...

Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche ...
DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Breast Cancer Market 2014-2018" report to their offering. Breast cancer is characterized ...Read More...

JD Breast Cancer Foundation Praises Ambiance for Generous Donation
CLEVELAND, Sept. 17, 2014 /PRNewswire/ -- In preparation for their annual Pink Carpet Gala, the Board of JD Breast Cancer Foundation (JDBCF) applauds Ambiance, The Store for Lovers, for its continued support ...Read More...

Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered ...
SAN FRANCISCO, Sept. 17, 2014 /PRNewswire/ -- A long-term retrospective study of breast cancer patients receiving accelerated partial breast irradiation (APBI) via interstitial brachytherapy suggests that ...Read More...

Breast Cancer Myths: Know Your Facts From Your Fiction
With Breast Cancer Awareness Month 2014 just around the corner, Britain is gearing up for its annual explosion of pink-themed products, parties, activities and events, to raise money for breast cancer research and increase awareness of the disease. But while its message may be delivered in pink packaging and tied with a pretty ribbon, the campaign has never tried to sugar coat the facts ...Read More...

ADVISORY - Breast Cancer Awareness Month: Canadian Cancer Society experts available to talk about research, early ...
TORONTO, Sept 16, 2014 /CNW/ - October is Breast Cancer Awareness Month and the Canadian Cancer Society is the authoritative source for reliable information about statistics, progress in research, importance of early detection and finding support services. Dr Kelly Fathers, PhD, Senior Manager, Research Communications, Ontario Division, can talk about cutting edge research funded by the Society ...Read More...